TOMI Environmental Solutions, Inc. (TOMZ) - Q1 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2025. TOMI Environmental Solutions, Inc. is a global provider of disinfection and decontamination solutions utilizing its proprietary Binary Ionization Technology (BIT) under the SteraMist brand. The company operates across four divisions: Life Sciences, Hospital Healthcare, Food Safety, and Commercial. As of May 6, 2025, there were 20,015,205 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Net Revenue | $1,576,558 | $1,114,087 |
| Gross Profit | $951,745 | $670,668 |
| Gross Margin | 60.4% | 60.2% |
| Operating Loss | $(754,465) | $(1,226,476) |
| Net Loss | $(255,593) | $(1,310,190) |
| Cash and Equivalents (End of Period) | $674,181 | $1,093,220 |
| Working Capital | $3,767,125 | $3,772,203 |
| Convertible Notes Payable (Net) | $2,622,707 | $2,360,494 |
Cash Flow: Net cash used in operating activities was $275,698 for Q1 2025, a significant improvement from the $1,178,499 used in Q1 2024. Financing activities provided $285,000, primarily from the issuance of convertible notes.
Material Changes vs. Prior Period
- Revenue Growth: Net revenue increased by 42% ($463,000) year-over-year, driven by a 35% increase in product sales and a 56% increase in service and training revenue.
- Geographic Shift: Domestic (U.S.) revenue surged 80% to $1.19 million, while international revenue declined 15% to $385,000 due to order timing.
- Expense Reduction: Total operating expenses decreased by 10% ($191,000), with specific reductions in Selling Expenses (15%) and General and Administrative expenses (11%) due to lower advertising costs and reduced executive salaries.
- Unusual Income: The company recorded $534,912 in "Other Income" related to Employee Retention Credits (ERC), a one-time non-operating benefit that significantly reduced the net loss.
- Debt Issuance: The company issued an additional $285,000 in convertible notes in March 2025, increasing total convertible debt.
Outlook, Risks, and Contingencies
- Going Concern: Management has raised substantial doubt about the company's ability to continue as a going concern within one year due to an accumulated deficit of $54.6 million and recurring operating losses. Continued operations depend on raising additional capital through equity or debt financings.
- Backlog: As of March 31, 2025, the sales backlog was approximately $1.225 million. Notable recent contracts include a $450,000 installation at a Rhode Island university and a deployment at NASA Johnson Space Center.
- Internal Controls: The company identified a material weakness in internal controls over financial reporting due to limited resources in the finance department and ineffective review procedures. Remediation plans are underway.
- Customer Concentration: One customer accounted for 10% of net revenue in Q1 2025. Two customers accounted for 25% of gross accounts receivable.
- Future Financing: The company has a facility to issue up to $3 million in additional convertible notes under a 2025 Securities Purchase Agreement.
Investor Verification Checklist
- ERC Sustainability: Verify the non-recurring nature of the $535k Employee Retention Credit income and its impact on the reported net loss.
- Liquidity Runway: Assess the sufficiency of the $674k cash balance against the $276k quarterly operating cash burn and the need for immediate capital raises.
- Debt Dilution: Review the terms of the $2.885 million convertible notes (12% interest, $1.25 conversion price) and the potential dilution to existing shareholders.
- Internal Control Remediation: Monitor progress on fixing the material weakness in financial reporting controls to ensure future financial statement reliability.
- Backlog Conversion: Track the conversion of the $1.225 million sales backlog into recognized revenue in upcoming quarters.